iTeos Therapeutics, Inc.

General ticker "ITOS" information:

  • Sector: Health Care
  • Industry: Biotechnology
  • Capitalization: $421.1M (TTM average)

iTeos Therapeutics, Inc. does not follow the US Stock Market performance with the rate: -8.9%.

Estimated limits based on current volatility of 0.9%: low 9.95$, high 10.10$

Factors to consider:

  • US accounted for 0.0% of revenue in the fiscal year ended 2024-12-31
  • Price in estimated range
  • Earnings for 3 months up through Q1 exceed our estimates

Stock Forecast*

* forecast is subjective and experimental, should not be used for any investment decisions

Long term estimates were made for the period from 2024-12-31 to 2026-12-31

  • 2024-12-31 to 2025-12-31 estimated range: [4.20$, 10.52$]
  • 2025-12-31 to 2026-12-31 estimated range: [3.94$, 9.62$]

Financial Metrics affecting the ITOS estimates:

  • Negative: Non-GAAP EPS, $ of -3.31 <= 0.05
  • Negative: negative Net income
  • Negative: Operating cash flow per share per price, % of -23.39 <= 1.99
  • Negative: Operating profit margin, % of -82.01 <= 0.04
  • Negative: -0.32 < Industry inventory ratio change (median), % of 0
  • Negative: Shareholder equity ratio, % of 85.93 > 63.58
  • Negative: Industry operating profit margin (median), % of -98.39 <= 0.07
  • Negative: Inventory ratio change, % of 10.24 > 0.93
  • Negative: Industry earnings per price (median), % of -24.73 <= 0

Similar symbols

Short-term ITOS quotes

Long-term ITOS plot with estimates

Financial data

YTD 2022-12-31 2023-12-31 2024-12-31
Operating Revenue $267.63MM $12.60MM $35.00MM
Operating Expenses $141.31MM $163.70MM $194.53MM
Operating Income $126.32MM $-151.10MM $-159.53MM
Non-Operating Income $22.41MM $42.07MM $39.19MM
R&D Expense $97.36MM $113.30MM $145.45MM
Income(Loss) $148.74MM $-109.03MM $-120.34MM
Taxes $52.08MM $3.61MM $14.07MM
Profit(Loss)* $96.65MM $-112.64MM $-134.41MM
Stockholders Equity $663.33MM $575.23MM $590.29MM
Assets $754.99MM $667.59MM $686.98MM
Operating Cash Flow $-111.19MM $-103.76MM $-98.18MM
Capital expenditure $0.94MM $2.97MM $1.63MM
Investing Cash Flow $-446.06MM $72.66MM $-131.15MM
Financing Cash Flow $1.98MM $1.11MM $122.24MM
Earnings Per Share** $2.72 $-3.15 $-3.32

* Profit(Loss) attributable to entity.
** EPS are Split Adjusted, recent splits may be reflected with a delay.